Skip to main content
CRBP
NASDAQ Life Sciences

CRB-701 获得 FDA 快速通道指定用于治疗头颈、宫颈癌

feedReported by Wiseek News
Sentiment info
Positive
Importance info
8
Price
$9.74
Mkt Cap
$167.632M
52W Low
$4.64
52W High
$20.56
Market data snapshot near publication time

summarizeSummary

Corbus Pharmaceuticals 的 CRB-701 已获得 FDA 快速通道指定，用于治疗头颈鳞状细胞癌和宫颈癌。这一重要的监管里程碑是在 Phase 1/2 试验数据显示 47.6% 的反应率之后获得的。快速通道状态是公司的一个重要积极催化剂，因为它可以加速开发和审查过程，可能加快药物的上市进程。这一消息为公司的肿瘤学管道提供了一个积极的发展，继最近报告 Q4 2025 的更大净亏损，但也获得了更长的现金跑道之后。投资者现在将关注进一步的临床试验进展和预计在 2026 年公布的数据读数，涉及其肿瘤学和肥胖症项目。

在该公告发布时，CRBP的交易价格为$9.74，交易所为NASDAQ，所属行业为Life Sciences，市值约为$1.7亿。 52周交易区间为$4.64至$20.56。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Wiseek News。

show_chartPrice Chart

Share this article

Copied!

feed CRBP - Latest Insights

CRBP
Apr 16, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Corbus Pharmaceuticals Updates CEO & CFO Employment Agreements with Enhanced Severance
Sentiment: Neutral
View Wiseek Article
CRBP
Apr 14, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Corbus Pharmaceuticals Completes Enrollment for Phase 1b Obesity Trial (CRB-913), Data Expected Summer 2026
Sentiment: Positive
View Wiseek Article
CRBP
Apr 07, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Corbus Pharmaceuticals Secures FDA Alignment for CRB-701 Registrational Path in HNSCC and Cervical Cancer
Sentiment: Positive
View Wiseek Article
CRBP
Apr 07, 2026, 8:05 AM EDT
Source: Reuters
Importance Score:
8
FDA Aligns with Corbus on CRB-701 Registration Path for Two Cancer Indications
Sentiment: Positive
View Wiseek Article
CRBP
Apr 02, 2026, 4:49 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Shareholders to Vote on Significant Equity Plan Expansion, Potentially Diluting Shares by 17%
Sentiment: Negative
View Wiseek Article
CRBP
Mar 11, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
8
Corbus Pharmaceuticals Registers $300M Universal Shelf for Future Capital Raises, Signaling Substantial Potential Dilution
Sentiment: Negative
View Wiseek Article
CRBP
Mar 09, 2026, 4:16 PM EDT
Filing Type: 10-K
Importance Score:
8
Corbus Pharma Secures $70.2M Funding at Premium, Advances Oncology & Obesity Programs
Sentiment: Positive
View Wiseek Article
CRBP
Mar 09, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
CRB-701 Receives FDA Fast Track Designation for Head and Neck, Cervical Cancers
Sentiment: Positive
View Wiseek Article
CRBP
Mar 09, 2026, 7:43 AM EDT
Filing Type: 8-K
Importance Score:
8
Corbus Pharmaceuticals Secures Funding into 2028, Reports Q4 Loss, and Updates Positive Clinical Data
Sentiment: Neutral
View Wiseek Article
CRBP
Mar 09, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Corbus Pharmaceuticals Reports $1.25 Per Share Loss in Q4
Sentiment: Negative
View Wiseek Article